NPI: 1497708473 · ROARING SPRING, PA 16673 · General Acute Care Hospital · NPI assigned 05/18/2006
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| NPI Enumeration Date | 05/18/2006 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 183 | $3K |
| 2019 | 26 | $670.62 |
| 2020 | 4,476 | $93K |
| 2021 | 28,578 | $613K |
| 2022 | 9,227 | $375K |
| 2023 | 8,172 | $305K |
| 2024 | 5,285 | $238K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3,138 | 3,038 | $469K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 4,448 | 4,366 | $324K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 2,902 | 2,829 | $309K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 789 | 758 | $60K |
| 80053 | Comprehensive metabolic panel | 3,588 | 3,365 | $34K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 798 | 788 | $30K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 411 | 396 | $30K |
| X0621 | 135 | 42 | $29K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 163 | 156 | $25K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 909 | 878 | $22K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 707 | 691 | $22K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4,229 | 3,908 | $21K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 927 | 896 | $16K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1,353 | 1,301 | $13K |
| 80050 | General health panel | 288 | 280 | $12K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,003 | 510 | $11K |
| 84443 | Thyroid stimulating hormone (TSH) | 518 | 507 | $10K |
| 70450 | Computed tomography, head or brain; without contrast material | 165 | 159 | $9K |
| 80061 | Lipid panel | 666 | 656 | $8K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 630 | 619 | $8K |
| 84484 | 889 | 696 | $7K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 851 | 777 | $7K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 915 | 835 | $6K |
| 96361 | Intravenous infusion, hydration; each additional hour | 464 | 449 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 169 | 166 | $5K |
| T1015 | Clinic visit/encounter, all-inclusive | 145 | 101 | $5K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 70 | 70 | $5K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 210 | 209 | $5K |
| 71046 | Radiologic examination, chest; 2 views | 377 | 362 | $5K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 14 | 14 | $5K |
| G0378 | Hospital observation service, per hour | 12 | 12 | $5K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 70 | 67 | $4K |
| 96375 | Therapeutic injection; each additional sequential IV push | 305 | 293 | $4K |
| 83735 | 693 | 626 | $4K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 129 | 125 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | 548 | 540 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 149 | 143 | $3K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 84 | 83 | $3K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 147 | 141 | $3K |
| 87040 | 270 | 168 | $3K | |
| 84703 | 355 | 343 | $3K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 72 | 67 | $3K |
| 84702 | 176 | 136 | $3K | |
| 85027 | 366 | 333 | $2K | |
| 85610 | 821 | 728 | $2K | |
| 84439 | 314 | 307 | $2K | |
| 81001 | 955 | 893 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 147 | 139 | $2K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 83 | 82 | $2K |
| 83690 | 549 | 523 | $2K | |
| 82607 | 178 | 176 | $2K | |
| 85730 | 368 | 345 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 262 | 246 | $2K |
| 84100 | 314 | 305 | $2K | |
| 81003 | 653 | 635 | $2K | |
| 87077 | 274 | 255 | $2K | |
| 87088 | 267 | 247 | $2K | |
| 87186 | 207 | 193 | $1K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 28 | 26 | $1K |
| 59025 | Fetal non-stress test | 223 | 78 | $1K |
| 36415 | Collection of venous blood by venipuncture | 6,294 | 5,649 | $1K |
| 83605 | 242 | 214 | $1K | |
| 71045 | Radiologic examination, chest; single view | 179 | 172 | $1K |
| 76830 | Ultrasound, transvaginal | 30 | 28 | $1K |
| 85379 | 156 | 143 | $1K | |
| 82570 | 181 | 174 | $1K | |
| 80305 | 118 | 114 | $1K | |
| 87070 | 183 | 175 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 170 | 167 | $1K |
| 87081 | 228 | 224 | $1K | |
| 86762 | 52 | 51 | $1K | |
| 83880 | 48 | 46 | $1K | |
| 86803 | 59 | 59 | $1K | |
| 0002A | 31 | 31 | $956.77 | |
| 86900 | 229 | 212 | $888.57 | |
| 82043 | 124 | 120 | $872.96 | |
| 82728 | 79 | 75 | $868.38 | |
| 85007 | 207 | 185 | $794.55 | |
| 85652 | 308 | 285 | $779.65 | |
| 86850 | 104 | 93 | $771.51 | |
| 86885 | 97 | 94 | $770.25 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 41 | 41 | $768.70 |
| 87340 | 54 | 52 | $740.22 | |
| 80076 | 80 | 78 | $693.79 | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 12 | 12 | $647.70 |
| 84481 | 29 | 28 | $609.42 | |
| 87807 | 46 | 45 | $596.38 | |
| 0001A | 33 | 33 | $570.77 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 28 | 27 | $558.06 |
| 86901 | 139 | 131 | $552.45 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 104 | 96 | $539.08 |
| 83540 | 61 | 59 | $500.46 | |
| 87205 | 126 | 119 | $489.75 | |
| 93000 | 26 | 25 | $450.80 | |
| 82150 | 113 | 109 | $429.00 | |
| 86140 | 161 | 150 | $424.34 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 169 | 161 | $394.25 |
| 86592 | 90 | 89 | $373.00 | |
| 82950 | 56 | 56 | $370.11 | |
| 73610 | 26 | 25 | $359.60 | |
| 84550 | 44 | 43 | $228.44 | |
| 86780 | 12 | 12 | $167.00 | |
| 81025 | 73 | 73 | $160.00 | |
| 82746 | 15 | 14 | $148.92 | |
| 83655 | 13 | 13 | $132.00 | |
| 73130 | 14 | 13 | $114.71 | |
| 73630 | 12 | 12 | $87.40 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 560 | 504 | $68.78 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 764 | 698 | $61.99 |
| J2704 | Injection, propofol, 10 mg | 440 | 268 | $57.64 |
| 82948 | 64 | 39 | $47.20 | |
| 85018 | 14 | 14 | $44.97 | |
| 85014 | 14 | 14 | $44.97 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 69 | 55 | $17.13 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 321 | 293 | $15.11 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 848 | 733 | $11.28 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 12 | 12 | $11.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 368 | 336 | $10.84 |
| J7050 | Infusion, normal saline solution, 250 cc | 152 | 135 | $6.58 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 385 | 356 | $2.59 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 293 | 262 | $1.26 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 26 | 13 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 31 | 26 | $0.00 |